| Management target | Revenue FY27 |
|---|
| Revenue growth | 54.6% YoY to ₹199.33 Cr, driven by retail expansion. |
|---|---|
| Margins | Sequential EBITDA improvement to 3.97% from negative in Q1. |
| Demand visibility | Strong acceptance of affordable generic medicines in urban/rural markets. |
| Management confidence | High, emphasizing store maturity and sequential recovery in EBITDA. |
Growth
Revenue grew 54.6% YoY to ₹199 Cr; Dawaa India sales increased 76% YoY.
Outlook
Management expects EBITDA to turn positive in Q4 FY27 with 400-450 new store additions.
Risks
Continued losses at the consolidated level and high marketing spend for brand ambassadors.
Last quarter's promises, checked
Delivered
- Guided reported EBITDA positive from next qtr → 3.97%, up from Q1 negative (= BEAT)
Partly delivered
- Guided 400–450 adds over Q2–Q4 → 20 added this qtr; 400–450 restated for H2 (= PARTIAL)
- Guided ~₹20 Cr qtr cash loss gone in 2–3 qtrs, cash breakeven by Q1 FY28 → PAT loss ₹25.96 Cr, no cash data (= PARTIAL)
- Guided FY27 marketing ₹40–45 Cr → Q1 spend ₹15–17 Cr, later qtrs undisclosed (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,323.60
- Market cap
- ₹4,584 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -40.6×Sector 48.7×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 6.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Results Update
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
- Key figure
- Net loss ₹26 Cr
Zota Healthcare Board Meeting Date
Zota Health Care will hold a board meeting on October 28, 2026. The meeting will consider the company's half-yearly unaudited financial results.
Zota Healthcare Price Movement Clarification
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Healthcare Business Update
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
- store expansion
- 20.0 stores
Zota Healthcare Capital Structure Change
Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.
- Value
- ₹2.10 Cr